The UK’s Continuous Mortality Investigation (CMI) carries out research into mortality and morbidity experience and produces practical tools that are widely used by actuaries. It published its most recent set of projections in July, showing lower life expectancies.
So, for August’s poll, we asked, ‘How Significant Will the Impact of the Latest CMI Data on UK Life Expectancy Be on Life Risk Markets?’
Our readers were split. 47% said they thought that the latest report was ‘very significant’ because we’ve not seen changes like this in some time, but 41.2% said that it wasn’t significant, because many other factors are considered when structuring a deal in the life risk markets.
Which cohort is correct remains to be seen – and in some cases, it’ll take years to learn the answer.